Impact of the Preventing Addiction-Related Suicide (PARS) Intervention on patients who receive community-based addiction treatment

Project Type(s):

Principal Investigator(s):
Co-Investigator(s):

Persons with substance use disorders are 5-10 times more likely to die by suicide than the general public. Recognizing this, Rick Ries, MD, Katherine (Kate) Comtois, PhD, MPH, and the UW Center for Suicide Prevention and Recovery (CSPAR) staff developed the first and only suicide prevention intervention successfully developed with and tested in community addiction treatment centers. The primary outcomes of the multisite PARS clinical published in JAMA Network Open in April 2022. Led by Dr. Ries, Kevin Hallgren, PhD, Amanda Kerbrat, LICSW, and Yanni Chang, MD, this project will fund a more detailed secondary analyses to better characterize which patients respond best to the PARS intervention, which in turn will help inform intervention improvements.

Project Period:
July 1, 2022 — June 30, 2023

Accepting Trainees?

No

Funding Type(s):
Internal

Funder(s):
Mary. E Nelson Charitable Remainder Trust, Heidi Combs Trustee

Research Program(s):

Geographic Area(s):
Washington

Practice Type(s):
Community Mental Health/Health Center/Faith Health Center

Patient Population(s):
Adults

Targeted Condition(s):
Substance use disorders/misuse, Suicidal Ideation